Skip to main content
SpringerLink
Log in

Interferon Therapy in Herpes Virus Infections

  • Chapter
Immune Deficiency and Cancer

  • 57 Accesses

Abstract

Interferon (IFN’s) are a family of proteins secreted by vertebrate cells antigenic or mitogenic stimulation, or stimulation by synthetic compounds, intracellular infection, microbial polysaccharides, or endotoxins. They show broad, partially species-specific antiviral activity by inducing certain cellular enzymes. Additionally, IFN exerts many regulatory functions (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Vilcek, J., Gresser, I., and Merigan, T.C. Regulatory functions of interferons. Annals NY Acad. Sci., 350:, 1980.

    Google Scholar 

  2. Lawn, R.M., Gross, M., Houck, C.M., Franke, A.E. et al. DNA sequence of a major human leukocyte interferon gene. Proc. Natl. Acad. Sci., 78:5435, 1981.

    Article  PubMed  CAS  Google Scholar 

  3. Ohno, S. and Taniguchi, T. Structure of a chromosomal gene for human interferon beta. Proc. Natl. Acad. Sci. USA, 78:5305, 1981.

    Article  PubMed  CAS  Google Scholar 

  4. Yip, Y.K., Barroclough, B.S., Urban, C., and Vilcek, J. Molecular weight of human gamma interferon is similar to that of other human interferons. Science, 215:411, 1982.

    Article  PubMed  CAS  Google Scholar 

  5. Gray, P.W., Leung, D.N., Yelverton, E. et al. Expression of human immune interferon cDNA in E. coli and monkey cells. Nature, 295:503, 1982.

    Article  PubMed  CAS  Google Scholar 

  6. Gresser, I. On the varied biological effects of interferon. Cell. Immunol., 40:406, 1977.

    Article  Google Scholar 

  7. Harfast, B., Muddlestone, J.R., Casali, P., Merigan, T.C., and Oldstone, M.B.A. Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis. J. Immunol., 127:2146, 1981.

    PubMed  CAS  Google Scholar 

  8. Herberman, R.B., Ortaldo, J.R., Mantovani, A. et al. Effect of human recombinant interferon on cytoxic activity of natural killer (NK) cells and monocytes. Cell. Immunol., 67:160, 1982.

    Article  PubMed  CAS  Google Scholar 

  9. Maluish, A.E., Ortaldo, J.R., Sherwin, S. et al. Immunological monitoring of patients receiving recombinant leukocyte A interferon. Abstracts of the 1982 ASCO meeting, St. Louis, 1982.

    Google Scholar 

  10. Troyl, M. Enhanced human NK cell activity following treatment with interferon in vitro and in vivo. In: Mediation of Cellular Immunity in Cancer by Immune Modifiers.

    Google Scholar 

  11. Sonnenbeld, G. and Merigan, T.C. A regulatory role for interferon in immunity. Annals NY Acad. Sci., 332:345, 1979.

    Article  Google Scholar 

  12. Overall, J.C., Yeh, T.J., and Kern, E.R. Sensitivity of Herpes simplex virus types I and II to three preparations of human interferon. J. Infect. Dis., 142:943, 1980.

    Article  PubMed  Google Scholar 

  13. Weck, P.K., Rinderknecht, E., Estell, D.A., and Stebbing, N. Antiviral activity of bacteria-derived human alpha interferons against encephalorayocarditis virus infection of mice. Infect. Immunol., 35:660, 1982.

    CAS  Google Scholar 

  14. Sullivan, J.L., Byron, K.S., Brewster, F.E., Sakamoto, K., Shaw, J.E., and Pagano, J.S. Treatment of life-threatening Epstein-Barr virus infections with Acyclovir®. Am. J. Med., 73:262, 1982.

    Article  PubMed  CAS  Google Scholar 

  15. Hammer, S.M., Kaplan, J.C., Lowe, B.R., and Hirsch, M.S. Alpha interferon and Acyclovir treatment of Herpes simplex virus in lymphoid cell cultures. Antimicrob. Ag. Chemother., 21:634, 1982.

    CAS  Google Scholar 

  16. Spector, S.A., Tyndall, M., and Kelley, E. Effect of Acyclovir-combined with other antiviral agents on human cytomegalovirus. Am. J. Med., 73:36, 1982.

    Article  PubMed  CAS  Google Scholar 

  17. Smith, C.I., Kitchen, L.W., Scullard, G.H., Robinson, W.S., Gregory, P.B., and Merigan, T.C. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection. J. Am. Med. Assoc., 247:2261, 1982.

    Article  CAS  Google Scholar 

  18. Smolin, G., Stebbing, N., Friedlaender, M., Friedlaender, R., and Okumoto, M. Natural and cloned human leukocyte interferon in herpes virus infections of rabbit eyes. Arch. Ophtalmol, 100:481, 1982.

    Article  CAS  Google Scholar 

  19. Nesburn, A.B. and Ziniti, P.J. Long-term topical poly 1:C in experimental chronic ocular herpes simplex infection. Am. J. Ophthalmol., 72:821, 1971.

    PubMed  CAS  Google Scholar 

  20. Trousdale, M.D., Dunkel, E.C., and Nesburn, A.B. Effect of Acyclovir on acute and latent herpes simplex virus infections in the rabbit. Invest. Ophthalmol. Vis. Sci. 19:1336, 1980.

    PubMed  CAS  Google Scholar 

  21. Wohlenberg, C., Openshaw, H., and Notkins, A.L. In vitro system for studying the efficacy of antiviral agents in preventing the reactivation of latent herpes simplex virus. Antimicrob. Ag. Chemother., 15:625, 1979.

    CAS  Google Scholar 

  22. Merigan, T.C. and Cunningham, A.L. Interferons as markers for immune response in man to viral antigens. Presented at the WHO Scientific Group on the Relevance of Recent Progress in Vaccines and Antiviral Drugs to the Prevention and Control of Viral Disease, London 5–9, July 1982.

    Google Scholar 

  23. Merigan, T.C. Present appraisal and future hopes for the clinical utilization of interferons. In: I. Gresser (ed.), Interferon III. New York: Academic Press, 1981.

    Google Scholar 

  24. Pazin, G.J., Armstrong, J.A., Lam, M.T., Tarr, G.C., Janetta, P.J., and Ho, M. Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N. Engl. J. Med., 301:225, 1979.

    Article  PubMed  CAS  Google Scholar 

  25. Sundmacher, R., Cantell, K., and Neumann-Haefflin, D. Combination therapy of dendritic keratitis in trifluorothymidine and interferon. Lancet, ii:687, 1978.

    Article  Google Scholar 

  26. Sundmacher, R., Cantell, K., Skoda, R., Hallermann, C., and Neumann-Haefelin, D. Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis. Albrecht von Graefes Arch. Klin. Ophthalmol. 208:229, 1978.

    CAS  Google Scholar 

  27. Arvin, A.M., Kushner, J.H., Feldman, S., Baehner, R.L., Hammond, D., and Merigan, T.C. Human leukocyte interferon for the treatment of varicella in children with cancer. N. Engl. J. Med. 306:761, 1982.

    Article  PubMed  CAS  Google Scholar 

  28. Arvin, A.M., Martin, D.P., and Merigan, T.C. Interferon prophyulaxis for varicella infection in Erythrocebus patas monkeys. J. Infect. Dis., in press, 1982.

    Google Scholar 

  29. Merigan, T.C., Rand, K.H., Pollard, R.B., Abdallah, P.S., Jordan, G.W., and Fried, R.P. Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N. Engl. J. Med., 298:981, 1978.

    Article  PubMed  CAS  Google Scholar 

  30. Merigan, T.C., Gallagher, J.G., Pollard, R.B., and Arvin, M. Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer. Antimicrob. Ag. Chemother., 19:193, 1981.

    CAS  Google Scholar 

  31. Stevens, D.A. and Merigan, T.C Interferon, antibody and other host factors in herpes zoster. J. Clin. Invest. 51:1170, 1972.

    Article  PubMed  CAS  Google Scholar 

  32. Balfour, H.H., Bean, B., Mitchell, C.D., Sachs, G.W., Boen, J.R., and Edelman, C.K. Acyclovir in immunocompromised patients with cytomegalovirus disease. A controlled trial at one institution. Am. J. Med., 73:241, 1982.

    Google Scholar 

  33. Cheeseman, S.H., Rubin, R.H., Stewart, J.A., Tolkoff-Rubin, N.E., Cosimi, A.B., Cantell, K., Gilbert, J., Winkle, S., Herrin, J.T., Black, P.H., Russell, P.S., and Hirsch, M.S. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. N. Engl. J. Med., 300:1345, 1979.

    Article  PubMed  CAS  Google Scholar 

  34. Hirsch, M.S., Schooley, R.T., Rubin, R.H., Tolkoff-Rubin, N., and Cantell, K. Interferon in renal transplant recipients. Presented at the Interferon meeting, Squaw Valley, March 1982.

    Google Scholar 

  35. Meyers, J.D., McGuffin, R.W., Neumann, P.E., Singer, J.W., and Thomas, E.D. Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation. J. Infect. Dis., 141:555, 1980.

    Article  PubMed  CAS  Google Scholar 

  36. Chou, S. and Merigan, T.C. Preliminary observations on the effect of human leukocyte interferon on viral excretion in CMV retinitis. Abstracts of the 6th Cold Spring Harbor meeting on herpes viruses, 1982.

    Google Scholar 

  37. Lopez, C., Fitzgerald, P.A., and Siegal, F.P. Severe acquired immunodeficiency syndrome in male homosexuals: diminished capacity to make interferon-alpha in vitro is associated with susceptibility to opportunistic infections. Submitted for publication 1982.

    Google Scholar 

  38. Thorley-Lawson, D. The transformation of adult but not newborn human lymphocytes by Epstein-Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein-Barr infection is mediated by interferon. J. Immunol., 126:829, 1981.

    PubMed  CAS  Google Scholar 

  39. Hanto, D.W., Frizzera, G., Gajl-Peczalska, K.J., Sakamoto, K., Purtilo, D.T., Balfour, H.H., Simmons, R.L., and Najarian, J.S. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: Acyclovir therapy and transition from polyclonal to monoclonal B cell proliferation. N. Engl. J. Med., 306:913, 1982.

    Article  PubMed  CAS  Google Scholar 

  40. Thestrup-Pederson, K., Esmann, V., Bisballe, S., Jensen, J.R., Pallesen, G., Hastrup, J., Madsen, M., Thorling, K., Grazia-Masucci, M., Saemundsen, A.K., and Ernberg, I. Epstein-Barr virus-induced lymphoproliferative disorder converting to fatal Burkitt-like lymphoma in a boy with interferon-inducible chromosomal defect. Lancet, ii:997, 1980.

    Article  Google Scholar 

  41. Cheeseman, S.H., Henle, W., Rubin, R., Tolkoff-Rubin, N.E., Cosimi, B., Cantell, K., Winkle, S., Herrin, J.T., Black, P.H., Russell, P.S., and Hirsch, M.S. Epstein-Barr virus infection in renal transplant patients: effect of antithymocyte globulin and interferon. Ann. Intern. Med., 93:39, 1980.

    PubMed  CAS  Google Scholar 

  42. Rhodes-Feuillette, A., Canivet, M., Devergie, A., Gluckman, E., Mazeron, M.-C., Perol, Y., and Peries, J. Circulating interferon after marrow transplant in cytomegalovirus infection. Lancet, i:1217, 1981.

    Article  Google Scholar 

  43. Chatterjee, S.N. and Jordan, G.W. Interferon in the circulation of renal transplant recipients. J. Inf. Dis., in press, 1982.

    Google Scholar 

  44. Cantell, K. and Hirvonen, S. Large-scale production of human leukocyte interferon containing 10» units per ml. J. Gen. Virol., 39:54l, 1978.

    Article  Google Scholar 

  45. Gutterman, J.U., Fine, S., Quesada, J., Horning, S.J., Levine, J.F., Alexonian, R., Bernhardt, L., Kramer, M., Spiegel, H., Colburn, W., Trown, P., Merigan, T.C., and Dziewanowski, Z. Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance and biological effects in cancer patients. Ann. Intern. Med., 96:549, 1982.

    PubMed  CAS  Google Scholar 

  46. Scott, G.M., Secher, D.S., Flowers, D., Bate, J., Cantell, K. and Tyrrell, D.A.J. Toxicity of interferon. Br. Med. J., 282:1345, 1981.

    Article  CAS  Google Scholar 

  47. Gutterman, J.U., Blumenschein, G.R., Alexanian, R., Yap, H-Y., Buzdar, A.U., Cabanellas, F., Hortobagyi, G.N., Hersh, E.M., Rasmussen, S.L., Harmon, M., Kramer, M., and Pestka, S. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma and malignant lymphoma. Ann. Int. Med., 93:399, 1980.

    PubMed  CAS  Google Scholar 

  48. Bartram, C.R., Morier, W., and Schmidt, A. Human fibroblast interferon does not induce chromosomal abnormalities. Lancet, i:1372, 1981.

    Article  Google Scholar 

  49. Valibracht, A., Treuner, J., Flehmig, B., Joesters, K.E., and Niethammer, D. Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon. Nature, 289:496, 1981.

    Article  Google Scholar 

  50. Panem, S., Check, I.J., Henriksen, D., and Vilcek, J. Antibodies to alpha-interferon in a patient with systemic lupus erythematosus. Submitted, 1982.

    Google Scholar 

  51. Bino, T., Edery, H., Gertler, A., and Rosenberg, H. Involvement of the kidney in catabolism of human leukocytes interferon. J. Gen. Virol., 59:39, 1982.

    Article  PubMed  CAS  Google Scholar 

  52. Spruance, S.L., Green, J.A., Chiu, G., Yeh, T.J., Wenerstrora, G., and Overall, J.C. Jr. Pathogenesis of herpes simplex labialis: correlation of vesicle fluid interferon with lesion age and virus titer. Infect. Immunol., 36:907, 1982.

    CAS  Google Scholar 

  53. O’Reilly, R.J., Chibbaro, A., Anser, E., and Lopez, C. Cell-mediated immune responses in patients with recurrent herpes simplex infections. II. Infection associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progentialis. J. Immunol., 118:1095, 1977.

    PubMed  Google Scholar 

  54. Kelsey, D.R., Overall, J.C. Jr., and Glasgow, L.A. Production of alpha and gamma interferons by spleen cells from cytomegalovirus-infected mice. Infect. Immunol., 36:651, 1982.

    CAS  Google Scholar 

  55. Fleischmann, W.R., Georgiades, J.A., Osborne, L.C., and Johnson, H.M. Potentiation of interferon activity by mixed preparations of fibroblastic and immune interferon. Infect. Immunol., 26:248, 1979.

    Google Scholar 

  56. Sonnenfeld, G., Salvin, S.B., and Younger, J.S. Cellular source of interferons in circulation of mice with delayed hypersensitivity. Infect. Immunol., 18:283, 1977.

    CAS  Google Scholar 

  57. Trown, P.W., Dennine, R.A., Kramer, M.J., Connell, E.V., Palleroni, A.V., Quesada, J., and Gutterman, J.U. Antibodies in human leucocyte interferons in cancer patients. Lancet, i:81, 1983.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of California, Davis, CA, USA

    Milan Fiala & Satya N. Chatterjee

Authors
  1. Milan Fiala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satya N. Chatterjee
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Nebraska Medical Center, Omaha, Nebraska, USA

    David T. Purtilo

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Publishing Corporation

About this chapter

Cite this chapter

Fiala, M., Chatterjee, S.N. (1984). Interferon Therapy in Herpes Virus Infections. In: Purtilo, D.T. (eds) Immune Deficiency and Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4760-6_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4760-6_22

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4762-0

  • Online ISBN: 978-1-4684-4760-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation